Russell Investments Group
PNT

Russell Investments Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Russell Investments Group’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,128
Closed -$54.2K – 3340
2023
Q3 		$54.2K Buy
+8,128
New +$67.6K ﹤0.01% 2740

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Russell Investments Group's PNT Position: Q4 2023 in Review

Russell Investments Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 8,128 shares — an estimated $54.2K sold.

Russell Investments Group first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $54.2K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Russell Investments Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Russell Investments Group sold 8,128 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $54.2K.
  • Russell Investments Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Russell Investments Group's POINT Biopharma Global Inc. Common Stock position peaked at $54.2K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Russell Investments Group's 13F filing for Q4 2023, filed 5 Feb 2024.